MetaADEDB 2.0 @ LMMD
clevidipine
(KPBZROQVTHLCDU-UHFFFAOYSA-N)
Structure
SMILES
CCCC(=O)OCOC(=O)C1=C(C)NC(=C(C1c1cccc(c1Cl)Cl)C(=O)OC)C
Type(s)
Approved; Investigational
ATC code(s)
C08CA16
Molecular Formula:
C21H23Cl2NO6
Molecular Weight:
456.316
Log P:
4.5740
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
90.93
CAS Number(s):
166432-28-6; 167221-71-8
Synonym(s)
1.
clevidipine
2.
Cleviprex
3.
butyroxymethyl methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
External Link(s)
MeSHC118563
PubChem Compound153994
BindingDB50088387
ChEBI135738
CHEMBLCHEMBL1237132
DrugBankDB04920
DrugCentral674
IUPHAR/BPS Guide to PHARMACOLOGY7468
KEGGdr:D08892
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Atrial FibrillationFAERS: 14SIDER
US FAERS
2HypotensionFAERS: 14SIDER
US FAERS
3Ventilation perfusion mismatchFAERS: 14US FAERS
4IleusFAERS: 11SIDER
US FAERS
5Drug ineffectiveFAERS: 9US FAERS
6HypoxiaFAERS: 9US FAERS
7Drug administration errorFAERS: 6US FAERS
8Infusion Site ExtravasationFAERS: 6US FAERS
9No adverse eventFAERS: 5US FAERS
10Product quality issueFAERS: 5US FAERS
11Product label issueFAERS: 4US FAERS
12TachycardiaFAERS: 4SIDER
US FAERS
13AgitationFAERS: 3US FAERS
14Blood triglycerides increasedFAERS: 3SIDER
US FAERS
15ColitisFAERS: 3US FAERS
16ExtravasationFAERS: 3US FAERS
17Gastric ulcerFAERS: 3US FAERS
18Infusion site swellingFAERS: 3US FAERS
19NauseaFAERS: 3SIDER
US FAERS
20RestlessnessFAERS: 3US FAERS
21Therapy non-responderFAERS: 3US FAERS
22ThrombophlebitisFAERS: 3US FAERS
23Blood creatinine increasedFAERS: 2US FAERS
24Blood pressure inadequately controlledFAERS: 2US FAERS
25BradycardiaFAERS: 2US FAERS
26Infusion site erythemaFAERS: 2US FAERS
27MalaiseFAERS: 2US FAERS
28Mental status changesFAERS: 2US FAERS
29Poor quality drug administeredFAERS: 2US FAERS
30Product contamination physicalFAERS: 2US FAERS
31Shunt blood flow excessiveFAERS: 2US FAERS
32Abnormal clotting factorFAERS: 1US FAERS
33Accidental exposureFAERS: 1US FAERS
34Acute myocardial infarctionFAERS: 1US FAERS
35Alanine Aminotransferase IncreasedFAERS: 1US FAERS
36Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
37Aspartate aminotransferase abnormalFAERS: 1US FAERS
38Blood bilirubin abnormalFAERS: 1US FAERS
39Blood magnesium abnormalFAERS: 1US FAERS
40Blood phosphorus abnormalFAERS: 1US FAERS
41Blood potassium abnormalFAERS: 1US FAERS
42Carotid artery occlusionFAERS: 1US FAERS
43Catheter site phlebitisFAERS: 1US FAERS
44Cerebrovascular accidentFAERS: 1US FAERS
45CyanosisFAERS: 1US FAERS
46Deep Vein ThrombosisFAERS: 1US FAERS
47DehydrationFAERS: 1US FAERS
48Diastolic dysfunctionFAERS: 1US FAERS
49Drug dose titration not performedFAERS: 1US FAERS
50Drug exposure during pregnancyFAERS: 1US FAERS
51Drug label confusionFAERS: 1US FAERS
52Drug titration errorFAERS: 1US FAERS
53Embolic strokeFAERS: 1US FAERS
54EpistaxisFAERS: 1US FAERS
55Food AllergyFAERS: 1US FAERS
56General physical health deteriorationFAERS: 1US FAERS
57HypersensitivityFAERS: 1SIDER
US FAERS
58Incorrect dose administered by deviceFAERS: 1US FAERS
59Incorrect dose administeredFAERS: 1US FAERS
60Incorrect drug administration durationFAERS: 1US FAERS
61Infusion site indurationFAERS: 1US FAERS
62Infusion site painFAERS: 1US FAERS
63Infusion site phlebitisFAERS: 1US FAERS
64Infusion site pruritusFAERS: 1US FAERS
65Infusion site warmthFAERS: 1US FAERS
66Injection site extravasationFAERS: 1US FAERS
67KetosisFAERS: 1US FAERS
68Laboratory test interferenceFAERS: 1US FAERS
69Medication ErrorFAERS: 1US FAERS
70PO2 decreasedFAERS: 1US FAERS
71PainFAERS: 1US FAERS
72PhlebitisFAERS: 1US FAERS
73Post procedural complicationFAERS: 1US FAERS
74Product label confusionFAERS: 1US FAERS
75Product physical issueFAERS: 1US FAERS
76Protein total abnormalFAERS: 1US FAERS
77Supraventricular tachycardiaFAERS: 1US FAERS
78Unresponsive to stimuliFAERS: 1US FAERS
79Urinary lipids presentFAERS: 1US FAERS
80UrticariaFAERS: 1US FAERS
81Withdrawal hypertensionFAERS: 1US FAERS
82Acute Coronary SyndromeSIDER
83HeadacheSIDER
84Myocardial InfarctionSIDER
85Reflex tachycardiaSIDER
86VomitingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120238

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.